List of Tables
Table 1. Global Drugs for Asthma and COPD Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Generic Drugs
Table 3. Major Manufacturers of Patented Drugs
Table 4. Global Drugs for Asthma and COPD Market Size Growth Rate by Application (2021-2027) & (MT)
Table 5. Global Drugs for Asthma and COPD Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Drugs for Asthma and COPD Sales by Regions (2016-2021) & (MT)
Table 7. Global Drugs for Asthma and COPD Sales Market Share by Regions (2016-2021)
Table 8. Global Drugs for Asthma and COPD Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Drugs for Asthma and COPD Sales Forecast by Region (2022-2027) & (MT)
Table 10. Global Drugs for Asthma and COPD Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Drugs for Asthma and COPD Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Drugs for Asthma and COPD Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Drugs for Asthma and COPD Sales by Manufacturers (2016-2021) (MT)
Table 14. Global Drugs for Asthma and COPD Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Drugs for Asthma and COPD Manufacturers by Revenue (US$ Million) in 2020
Table 16. Drugs for Asthma and COPD Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Drugs for Asthma and COPD Revenue Share by Manufacturers (2016-2021)
Table 18. Global Drugs for Asthma and COPD Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Drugs for Asthma and COPD by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Asthma and COPD as of 2020)
Table 20. Key Manufacturers Drugs for Asthma and COPD Price (2016-2021) (USD/Kg)
Table 21. Drugs for Asthma and COPD Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Drugs for Asthma and COPD Product Type
Table 23. Date of International Manufacturers Enter into Drugs for Asthma and COPD Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Drugs for Asthma and COPD Sales by Type (2016-2021) (MT)
Table 26. Global Drugs for Asthma and COPD Sales Share by Type (2016-2021)
Table 27. Global Drugs for Asthma and COPD Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Drugs for Asthma and COPD Revenue Share by Type (2016-2021)
Table 29. Drugs for Asthma and COPD Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
Table 30. Global Drugs for Asthma and COPD Sales Forecast by Type (2022-2027) & (MT)
Table 31. Global Drugs for Asthma and COPD Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Drugs for Asthma and COPD Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Drugs for Asthma and COPD Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Drugs for Asthma and COPD Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)
Table 35. Global Drugs for Asthma and COPD Sales by Application (2016-2021) (MT)
Table 36. Global Drugs for Asthma and COPD Sales Share by Application (2016-2021)
Table 37. Global Drugs for Asthma and COPD Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Drugs for Asthma and COPD Revenue Share by Application (2016-2021)
Table 39. Drugs for Asthma and COPD Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
Table 40. Global Drugs for Asthma and COPD Sales Forecast by Application (2022-2027) & (MT)
Table 41. Global Drugs for Asthma and COPD Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Drugs for Asthma and COPD Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Drugs for Asthma and COPD Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Drugs for Asthma and COPD Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)
Table 45. USA Drugs for Asthma and COPD Sales (MT) of Key Companies (2016-2021)
Table 46. USA Drugs for Asthma and COPD Sales Share by Company (2016-2021)
Table 47. USA Drugs for Asthma and COPD Revenue (US$ Million) by Company (2016-2021)
Table 48. USA Drugs for Asthma and COPD Revenue Share by Company (2016-2021)
Table 49. USA Drugs for Asthma and COPD Sales (MT) by Type (2016-2021)
Table 50. USA Drugs for Asthma and COPD Sales Share by Type (2016-2021)
Table 51. USA Drugs for Asthma and COPD Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. USA Drugs for Asthma and COPD Price (USD/Kg) by Type (2016-2021)
Table 53. USA Drugs for Asthma and COPD Sales (MT) by Type (2022-2027)
Table 54. USA Drugs for Asthma and COPD Sales Share by Type (2022-2027)
Table 55. USA Drugs for Asthma and COPD Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. USA Drugs for Asthma and COPD Revenue Share by Type (2022-2027)
Table 57. USA Drugs for Asthma and COPD Price (USD/Kg) by Type (2022-2027)
Table 58. USA Drugs for Asthma and COPD Sales (MT) by Application (2016-2021)
Table 59. USA Drugs for Asthma and COPD Sales Share by Application (2016-2021)
Table 60. USA Drugs for Asthma and COPD Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. USA Drugs for Asthma and COPD Price (USD/Kg) by Application (2016-2021)
Table 62. USA Drugs for Asthma and COPD Sales (MT) by Application (2022-2027)
Table 63. USA Drugs for Asthma and COPD Sales Share by Application (2022-2027)
Table 64. USA Drugs for Asthma and COPD Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. USA Drugs for Asthma and COPD Revenue Share by Application (2022-2027)
Table 66. USA Drugs for Asthma and COPD Price (USD/Kg) by Application (2022-2027)
Table 67. North America Drugs for Asthma and COPD Sales by Country (2016-2021) & (MT)
Table 68. North America Drugs for Asthma and COPD Sales Market Share by Country (2016-2021)
Table 69. North America Drugs for Asthma and COPD Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Drugs for Asthma and COPD Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Drugs for Asthma and COPD Sales by Region (2016-2021) & (MT)
Table 72. Asia Pacific Drugs for Asthma and COPD Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Drugs for Asthma and COPD Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Drugs for Asthma and COPD Revenue Market Share by Region (2016-2021)
Table 75. Europe Drugs for Asthma and COPD Sales by Country (2016-2021) & (MT)
Table 76. Europe Drugs for Asthma and COPD Sales Market Share by Country (2016-2021)
Table 77. Europe Drugs for Asthma and COPD Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Drugs for Asthma and COPD Revenue Market Share by Country (2016-2021)
Table 79. Latin America Drugs for Asthma and COPD Sales by Country (2016-2021) & (MT)
Table 80. Latin America Drugs for Asthma and COPD Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Drugs for Asthma and COPD Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Drugs for Asthma and COPD Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Drugs for Asthma and COPD Sales by Country (2016-2021) & (MT)
Table 84. Middle East and Africa Drugs for Asthma and COPD Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Drugs for Asthma and COPD Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Drugs for Asthma and COPD Revenue Market Share by Country (2016-2021)
Table 87. GSK Corporation Information
Table 88. GSK Description and Business Overview
Table 89. GSK Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 90. GSK Drugs for Asthma and COPD Product
Table 91. GSK Recent Development
Table 92. Novartis Corporation Information
Table 93. Novartis Description and Business Overview
Table 94. Novartis Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 95. Novartis Product
Table 96. Novartis Recent Development
Table 97. Merck Corporation Information
Table 98. Merck Description and Business Overview
Table 99. Merck Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 100. Merck Product
Table 101. Merck Recent Development
Table 102. Abbott Corporation Information
Table 103. Abbott Description and Business Overview
Table 104. Abbott Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 105. Abbott Product
Table 106. Abbott Recent Development
Table 107. Boehringer Ingelheim Corporation Information
Table 108. Boehringer Ingelheim Description and Business Overview
Table 109. Boehringer Ingelheim Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 110. Boehringer Ingelheim Product
Table 111. Boehringer Ingelheim Recent Development
Table 112. AstraZeneca Corporation Information
Table 113. AstraZeneca Description and Business Overview
Table 114. AstraZeneca Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 115. AstraZeneca Product
Table 116. AstraZeneca Recent Development
Table 117. Roche Corporation Information
Table 118. Roche Description and Business Overview
Table 119. Roche Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 120. Roche Product
Table 121. Roche Recent Development
Table 122. Teva Corporation Information
Table 123. Teva Description and Business Overview
Table 124. Teva Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 125. Teva Product
Table 126. Teva Recent Development
Table 127. Vectura Corporation Information
Table 128. Vectura Description and Business Overview
Table 129. Vectura Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 130. Vectura Product
Table 131. Vectura Recent Development
Table 132. Pfizer Corporation Information
Table 133. Pfizer Description and Business Overview
Table 134. Pfizer Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 135. Pfizer Product
Table 136. Pfizer Recent Development
Table 137. Mylan Corporation Information
Table 138. Mylan Description and Business Overview
Table 139. Mylan Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 140. Mylan Product
Table 141. Mylan Recent Development
Table 142. Allergan Corporation Information
Table 143. Allergan Description and Business Overview
Table 144. Allergan Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 145. Allergan Product
Table 146. Allergan Recent Development
Table 147. Cipla Corporation Information
Table 148. Cipla Description and Business Overview
Table 149. Cipla Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 150. Cipla Product
Table 151. Cipla Recent Development
Table 152. Akorn Corporation Information
Table 153. Akorn Description and Business Overview
Table 154. Akorn Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 155. Akorn Product
Table 156. Akorn Recent Development
Table 157. Apotex Corporation Information
Table 158. Apotex Description and Business Overview
Table 159. Apotex Drugs for Asthma and COPD Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 160. Apotex Product
Table 161. Apotex Recent Development
Table 162. Drugs for Asthma and COPD Market Trends
Table 163. Drugs for Asthma and COPD Market Drivers
Table 164. Drugs for Asthma and COPD Market Challenges
Table 165. Drugs for Asthma and COPD Market Restraints
Table 166. Drugs for Asthma and COPD Customers List
Table 167. Drugs for Asthma and COPD Distributors List
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Asthma and COPD Product Picture
Figure 2. Global Drugs for Asthma and COPD Sales Market Share by Type in 2020 & 2027
Figure 3. Generic Drugs Product Picture
Figure 4. Patented Drugs Product Picture
Figure 5. Global Drugs for Asthma and COPD Sales Market Share by Application in 2020 & 2027
Figure 6. Asthma
Figure 7. COPD
Figure 8. Drugs for Asthma and COPD Report Years Considered
Figure 9. Global Drugs for Asthma and COPD Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Drugs for Asthma and COPD Market Size 2016-2027 (US$ Million)
Figure 11. Global Drugs for Asthma and COPD Sales 2016-2027 (MT)
Figure 12. Global Drugs for Asthma and COPD Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Drugs for Asthma and COPD Sales Market Share by Region (2016-2021)
Figure 14. Global Drugs for Asthma and COPD Sales Market Share by Region in 2020
Figure 15. Global Drugs for Asthma and COPD Revenue Market Share by Region (2016-2021)
Figure 16. Global Drugs for Asthma and COPD Revenue Market Share by Region in 2020
Figure 17. Global Drugs for Asthma and COPD Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Drugs for Asthma and COPD Revenue in 2020
Figure 19. Drugs for Asthma and COPD Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Drugs for Asthma and COPD Sales Market Share by Type (2016-2021)
Figure 21. Global Drugs for Asthma and COPD Sales Market Share by Type in 2020
Figure 22. Global Drugs for Asthma and COPD Revenue Market Share by Type (2016-2021)
Figure 23. Global Drugs for Asthma and COPD Revenue Market Share by Type in 2020
Figure 24. Global Drugs for Asthma and COPD Sales Market Share by Application (2016-2021)
Figure 25. Global Drugs for Asthma and COPD Sales Market Share by Application in 2020
Figure 26. Global Drugs for Asthma and COPD Revenue Market Share by Application (2016-2021)
Figure 27. Global Drugs for Asthma and COPD Revenue Market Share by Application in 2020
Figure 28. USA Drugs for Asthma and COPD Sales Growth Rate 2016-2027 (MT)
Figure 29. USA Drugs for Asthma and COPD Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. USA Drugs for Asthma and COPD Market Share in Global Market 2016-2027
Figure 31. USA 5 and 10 Largest Drugs for Asthma and COPD Players Market Share by Revenue in Drugs for Asthma and COPD in 2020
Figure 32. USA Drugs for Asthma and COPD Revenue Share by Type (2016-2021)
Figure 33. USA Drugs for Asthma and COPD Revenue Growth Rate by Type in 2016 & 2020
Figure 34. USA Drugs for Asthma and COPD Revenue Share by Application (2016-2021)
Figure 35. USA Drugs for Asthma and COPD Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Drugs for Asthma and COPD Sales Growth Rate 2016-2021 (MT)
Figure 37. North America Drugs for Asthma and COPD Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Drugs for Asthma and COPD Sales Market Share by Country in 2020
Figure 39. North America Drugs for Asthma and COPD Revenue Market Share by Country in 2020
Figure 40. the United States Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 41. the United States Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 43. Canada Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Drugs for Asthma and COPD Sales Growth Rate 2016-2021 (MT)
Figure 45. Europe Drugs for Asthma and COPD Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Drugs for Asthma and COPD Sales Market Share by Country in 2020
Figure 47. Europe Drugs for Asthma and COPD Revenue Market Share by Country in 2020
Figure 48. Germany Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 49. Germany Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 51. France Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. UK Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 53. UK Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 55. Italy Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 57. Russia Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Drugs for Asthma and COPD Sales Growth Rate 2016-2021 (MT)
Figure 59. Asia Pacific Drugs for Asthma and COPD Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Drugs for Asthma and COPD Sales Market Share by Region in 2020
Figure 61. Asia Pacific Drugs for Asthma and COPD Revenue Market Share by Region in 2020
Figure 62. China Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 63. China Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 65. Japan Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 67. South Korea Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 69. India Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 71. Australia Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. China Taiwan Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 73. China Taiwan Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 75. Indonesia Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 77. Thailand Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 79. Malaysia Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Latin America Drugs for Asthma and COPD Sales Growth Rate 2016-2021 (MT)
Figure 81. Latin America Drugs for Asthma and COPD Revenue Growth Rate 2016-2021 (US$ Million)
Figure 82. Latin America Drugs for Asthma and COPD Sales Market Share by Country in 2020
Figure 83. Latin America Drugs for Asthma and COPD Revenue Market Share by Country in 2020
Figure 84. Mexico Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 85. Mexico Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Brazil Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 87. Brazil Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Argentina Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 89. Argentina Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Middle East and Africa Drugs for Asthma and COPD Sales Growth Rate 2016-2021 (MT)
Figure 91. Middle East and Africa Drugs for Asthma and COPD Revenue Growth Rate 2016-2021 (US$ Million)
Figure 92. Middle East and Africa Drugs for Asthma and COPD Sales Market Share by Country in 2020
Figure 93. Middle East and Africa Drugs for Asthma and COPD Revenue Market Share by Country in 2020
Figure 94. Turkey Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 95. Turkey Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Saudi Arabia Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 97. Saudi Arabia Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. UAE Drugs for Asthma and COPD Sales Growth Rate (2016-2021) (MT)
Figure 99. UAE Drugs for Asthma and COPD Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Drugs for Asthma and COPD Value Chain
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Bottom-up and Top-down Approaches for This Report
Figure 104. Data Triangulation
Figure 105. Key Executives Interviewed
